Roslin, United Kingdom · Founded 2013 · Privately Held (backing)
Operator of a biotechnology company intended for medical research, disease modeling, and drug development. Axol Bioscience is based in Roslin, United Kingdom and was founded in 2013. Its last reported valuation was $128 million in Aug 2017. It has raised $19.9 million.
Last reported valuation
$128.1M
Oct 2026
Priced at
—
Total raised
$19.9M
Last round
—
How much has Axol Bioscience raised?
$19.9Macross 0 recorded rounds
Free account
More of Axol Bioscience with a free account
·The complete investor list: 14 names
·Watch Axol Bioscience: the Monday email on marks, rounds and moves